The effect of rosiglitazone and repaglinide on pathophysiology in patients with newly diagnosed type 2 diabetes
DENG Wen-juan
MA Xiao-jing
QIU Hui-ling
LU Jun-xi
LU Hui-juan
BAO Yu-qian
JIA Weiping
Machine-generated Keywords：
Publication Date：2010-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)